+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Monkeypox Virus Real Time PCR Test Kit Market - Global Forecast 2026-2032- Product Image
Monkeypox Virus Real Time PCR Test Kit Market - Global Forecast 2026-2032- Product Image
New

Monkeypox Virus Real Time PCR Test Kit Market - Global Forecast 2026-2032

  • Report

  • 193 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283443
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Monkeypox Virus Real-Time PCR Test Kits: Executive Summary

Monkeypox virus real-time PCR test kits support molecular detection of viral genetic material in clinical specimens. Their relevance is shaped by outbreak preparedness, laboratory capacity, diagnostic quality requirements, sample-to-answer workflow needs, and the ability of health systems to expand testing when suspected cases emerge. This summary focuses on evidence-based structural developments across technology, regulation, public health, and geography without presenting market estimates or forecasts.

Diagnostic Systems Are Shifting Toward Faster, More Flexible Outbreak Readiness

The diagnostic landscape is moving from episodic emergency response toward sustained preparedness. Laboratories increasingly value assays with validated performance, clear specimen requirements, robust controls, straightforward extraction workflows, and compatibility with established molecular platforms. Decentralized and near-patient testing can improve access where centralized capacity is limited, while reference laboratories remain important for confirmation, surveillance, quality assurance, and unusual or complex cases. Regulatory documentation, supply continuity, biosafety procedures, and trained personnel remain central to dependable deployment.

Artificial Intelligence Strengthens Workflow Management More Than Core Detection

Artificial intelligence can contribute to this market through laboratory workflow optimization, demand and inventory monitoring, instrument maintenance, result triage, and linkage of diagnostic data with epidemiological surveillance. It may also help identify inconsistent records or prioritize confirmatory review. However, AI does not replace analytical validation, controls, clinical interpretation, or regulatory oversight. Reliable implementation depends on representative data, cybersecurity, transparent performance evaluation, and human review of clinically significant results.

Regional Readiness Depends on Laboratory Networks, Regulation, and Access

North America generally combines advanced reference-laboratory infrastructure with established molecular testing and public-health surveillance systems, while procurement continuity and equitable access remain practical concerns. Europe benefits from interconnected surveillance and laboratory networks, with implementation influenced by national systems and European Union coordination. Asia-Pacific presents substantial diversity: several economies have sophisticated molecular capacity, while remote and lower-resource settings may require stronger specimen transport, training, and decentralized workflows. Latin America continues to emphasize laboratory strengthening, cross-border surveillance, and dependable access to validated testing. The Middle East is shaped by specialized clinical centers, emergency preparedness, and varying regulatory pathways. Africa’s priorities include expanding molecular infrastructure, improving transport and biosafety systems, and integrating outbreak testing with broader public-health laboratory programs.

Multilateral and Regional Groupings Shape Procurement and Preparedness

ASEAN countries face varied laboratory maturity and benefit from shared protocols, regional information exchange, and coordinated training. BRICS members span large and diverse health systems, making domestic production, resilient supply chains, and interoperable surveillance important themes. The European Union supports cross-border coordination, common public-health objectives, and laboratory collaboration, while national implementation remains significant. G7 members typically emphasize advanced surveillance, quality systems, and preparedness financing, with opportunities to support international capacity building. GCC countries can leverage centralized procurement, specialized hospitals, and coordinated emergency planning, while addressing workforce and referral-network requirements. NATO members may place additional emphasis on continuity of diagnostics, civil preparedness, biosafety, and interoperable response planning.

Country Priorities Reflect Different Capacity, Policy, and Access Conditions

Australia emphasizes national reference capacity, geographically distributed access, and outbreak surveillance. Brazil’s priorities include strengthening regional laboratory networks and dependable specimen logistics. Canada combines federal and provincial responsibilities, making coordination and standardized testing pathways important. China’s large laboratory ecosystem supports broad preparedness, with regulatory and surveillance alignment remaining central. France, Germany, Italy, and Spain operate within European surveillance and regulatory structures while maintaining national laboratory capabilities. India’s scale highlights the need for decentralized access, workforce development, and resilient procurement. Japan and South Korea emphasize technically advanced laboratories, quality assurance, and rapid public-health response. Mexico continues to benefit from stronger regional coordination and laboratory access across varied settings. Russia’s priorities include maintaining domestic diagnostic capacity, surveillance, and supply continuity. The United Kingdom and United States combine strong reference networks with ongoing attention to readiness, equitable access, and integration of clinical and public-health testing.

Industry Leaders Should Build Validated, Resilient, and Interoperable Testing Programs

Leaders should prioritize assays supported by transparent analytical and clinical validation, clear instructions for use, appropriate internal controls, and dependable performance across relevant specimen types. They should maintain diversified sourcing for critical reagents and consumables, establish inventory triggers, and plan for surge demand without compromising quality. Partnerships with public-health laboratories can improve proficiency testing, surveillance integration, and outbreak response. Product design should support existing laboratory platforms where possible, while decentralized options should be assessed for biosafety, operator training, connectivity, and confirmatory referral. Finally, organizations should evaluate AI-enabled workflow tools cautiously, using governance, cybersecurity, human oversight, and measurable operational outcomes.

Research Methodology: Evidence-Based Review of Diagnostic and Preparedness Drivers

This executive summary uses the defined market scope-monkeypox virus real-time PCR test kits-and synthesizes established diagnostic, laboratory, regulatory, and public-health considerations. The assessment is organized across technology adoption, workflow requirements, preparedness, artificial intelligence, regional systems, country conditions, and institutional groupings. It avoids market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims. Geographic observations are qualitative and intended to highlight structural differences in capacity, coordination, access, and implementation requirements. Conclusions should be supplemented with current regulatory documents, national guidance, laboratory validation studies, procurement records, and surveillance publications before operational decisions are made.

Preparedness and Quality Will Define Sustainable Adoption

The strategic importance of monkeypox virus real-time PCR test kits extends beyond individual assay performance. Effective use depends on validated methods, trained personnel, reliable supplies, safe specimen handling, connected surveillance, and the ability to scale testing across centralized and decentralized settings. Regional and national differences make adaptable implementation essential. Organizations that combine scientific rigor with resilient operations, responsible digital tools, and coordinated public-health partnerships will be better positioned to support timely detection and sustained outbreak readiness.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Monkeypox Virus Real Time PCR Test Kit Market, by Test Type
7.1. Introduction
7.2. Real-Time PCR Kit
7.3. Multiplex PCR Kit
7.4. Quantitative PCR (qPCR) Kit
7.5. Point-of-Care / Rapid PCR Kit
8. Monkeypox Virus Real Time PCR Test Kit Market, by Target Detection
8.1. Introduction
8.2. Monkeypox Virus DNA
8.3. Orthopoxvirus Family Detection
9. Monkeypox Virus Real Time PCR Test Kit Market, by Sample Type
9.1. Introduction
9.2. Blood / Plasma / Serum
9.3. Swabs
9.4. Saliva
9.5. Tissue Biopsy
10. Monkeypox Virus Real Time PCR Test Kit Market, by End-User Industry
10.1. Introduction
10.2. Hospitals & Clinical Laboratories
10.3. Public Health & Government Agencies
10.4. Research & Academic Institutions
10.5. Diagnostic Companies & Test Providers
11. Monkeypox Virus Real Time PCR Test Kit Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Monkeypox Virus Real Time PCR Test Kit Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Monkeypox Virus Real Time PCR Test Kit Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Aegis Sciences Corporation
15.3. Altona Diagnostics GmbH
15.4. Applied DNA Sciences Inc
15.5. Becton Dickinson and Company
15.6. BioGX LLC
15.7. BioPerfectus Technologies Inc
15.8. Bio-Rad Laboratories Inc
15.9. Bruker Corporation
15.10. CerTest Biotec SL
15.11. Danaher Corporation
15.12. DiaCarta Inc
15.13. F. Hoffmann-La Roche Ltd
15.14. HA TECH Pty Ltd
15.15. Hologic Inc
15.16. Jiangsu Macro and Micro-Test Med-Tech Co Ltd
15.17. LG Chem Ltd
15.18. Luminex Corporation
15.19. PerkinElmer Inc
15.20. QIAGEN N.V.
15.21. Shanghai ZJ Bio-Tech Co Ltd
15.22. Siemens Healthcare GmbH
15.23. Sonic Healthcare Ltd
15.24. Thermo Fisher Scientific Inc
15.25. Tianlong Science and Technology Co Ltd
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Monkeypox Virus Real Time PCR Test Kit Market, Years Considered for the Study
FIGURE 2. Global Monkeypox Virus Real Time PCR Test Kit Market, Research Design
FIGURE 3. Global Monkeypox Virus Real Time PCR Test Kit Market, Research Framework
FIGURE 4. Global Monkeypox Virus Real Time PCR Test Kit Market, Data Triangulation
FIGURE 5. Global Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 7. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2025 vs 2032 (%)
FIGURE 9. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2025 vs 2032 (%)
FIGURE 13. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Monkeypox Virus Real Time PCR Test Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Monkeypox Virus Real Time PCR Test Kit Market Segmentation & Coverage
TABLE 2. Global Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 4. Global Real-Time PCR Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Real-Time PCR Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Real-Time PCR Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Multiplex PCR Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Multiplex PCR Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Multiplex PCR Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Quantitative PCR (qPCR) Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Quantitative PCR (qPCR) Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Quantitative PCR (qPCR) Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Point-of-Care / Rapid PCR Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Point-of-Care / Rapid PCR Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Point-of-Care / Rapid PCR Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 17. Global Monkeypox Virus DNA Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Monkeypox Virus DNA Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Monkeypox Virus DNA Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Orthopoxvirus Family Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Orthopoxvirus Family Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Orthopoxvirus Family Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 24. Global Blood / Plasma / Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Blood / Plasma / Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Blood / Plasma / Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Swabs Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Swabs Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Swabs Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Tissue Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Tissue Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Tissue Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 37. Global Hospitals & Clinical Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Hospitals & Clinical Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Hospitals & Clinical Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Public Health & Government Agencies Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Public Health & Government Agencies Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Public Health & Government Agencies Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Research & Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Research & Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Research & Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Diagnostic Companies & Test Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Diagnostic Companies & Test Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Diagnostic Companies & Test Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 55. North America Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. North America Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 57. North America Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 58. North America Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 59. North America Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 60. Latin America Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Latin America Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 62. Latin America Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 63. Latin America Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 64. Latin America Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 65. Europe Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Europe Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 67. Europe Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 68. Europe Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 69. Europe Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 70. Middle East Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Middle East Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 72. Middle East Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 73. Middle East Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 74. Middle East Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 75. Africa Monkeypox Virus Real Time PCR Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Africa Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 77. Africa Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 78. Africa Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 79. Africa Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 80. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. ASEAN Monkeypox Virus Real Time PCR Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. ASEAN Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 83. ASEAN Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 84. ASEAN Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 85. ASEAN Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 86. GCC Monkeypox Virus Real Time PCR Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. GCC Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 88. GCC Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 89. GCC Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 90. GCC Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 91. European Union Monkeypox Virus Real Time PCR Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. European Union Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 93. European Union Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 94. European Union Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 95. European Union Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 96. BRICS Monkeypox Virus Real Time PCR Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. BRICS Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 98. BRICS Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 99. BRICS Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 100. BRICS Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 101. G7 Monkeypox Virus Real Time PCR Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. G7 Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 103. G7 Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 104. G7 Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 105. G7 Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 106. NATO Monkeypox Virus Real Time PCR Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. NATO Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 108. NATO Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 109. NATO Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 110. NATO Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 111. Global Monkeypox Virus Real Time PCR Test Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. United States Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 113. United States Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 114. United States Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 115. United States Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 116. United States Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 117. Canada Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 118. Canada Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 119. Canada Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 120. Canada Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 121. Canada Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 122. Mexico Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 123. Mexico Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 124. Mexico Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 125. Mexico Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 126. Mexico Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 127. Brazil Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 128. Brazil Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 129. Brazil Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 130. Brazil Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 131. Brazil Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 132. United Kingdom Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 133. United Kingdom Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 134. United Kingdom Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 135. United Kingdom Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 136. United Kingdom Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 137. Germany Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 138. Germany Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 139. Germany Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 140. Germany Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 141. Germany Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 142. France Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 143. France Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 144. France Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 145. France Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 146. France Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 147. Russia Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 148. Russia Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 149. Russia Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 150. Russia Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 151. Russia Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 152. Italy Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 153. Italy Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 154. Italy Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 155. Italy Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 156. Italy Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 157. Spain Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 158. Spain Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 159. Spain Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 160. Spain Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 161. Spain Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 162. China Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 163. China Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 164. China Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 165. China Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 166. China Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 167. India Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 168. India Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 169. India Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 170. India Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 171. India Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 172. Japan Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 173. Japan Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 174. Japan Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 175. Japan Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 176. Japan Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 177. Australia Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 178. Australia Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 179. Australia Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 180. Australia Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 181. Australia Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 182. South Korea Monkeypox Virus Real Time PCR Test Kit Market Size, 2017-2032 (USD Million)
TABLE 183. South Korea Monkeypox Virus Real Time PCR Test Kit Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 184. South Korea Monkeypox Virus Real Time PCR Test Kit Market Size, by Target Detection, 2017-2032 (USD Million)
TABLE 185. South Korea Monkeypox Virus Real Time PCR Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 186. South Korea Monkeypox Virus Real Time PCR Test Kit Market Size, by End-User Industry, 2017-2032 (USD Million)
TABLE 187. Global Monkeypox Virus Real Time PCR Test Kit Market Share, by Key Player, 2025
TABLE 188. Global Monkeypox Virus Real Time PCR Test Kit Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Aegis Sciences Corporation
  • Altona Diagnostics GmbH
  • Applied DNA Sciences Inc
  • Becton Dickinson and Company
  • BioGX LLC
  • BioPerfectus Technologies Inc
  • Bio‑Rad Laboratories Inc
  • Bruker Corporation
  • CerTest Biotec SL
  • Danaher Corporation
  • DiaCarta Inc
  • F. Hoffmann‑La Roche Ltd
  • HA TECH Pty Ltd
  • Hologic Inc
  • Jiangsu Macro and Micro‑Test Med‑Tech Co Ltd
  • LG Chem Ltd
  • Luminex Corporation
  • PerkinElmer Inc
  • QIAGEN N.V.
  • Shanghai ZJ Bio‑Tech Co Ltd
  • Siemens Healthcare GmbH
  • Sonic Healthcare Ltd
  • Thermo Fisher Scientific Inc
  • Tianlong Science and Technology Co Ltd

Related Topics

Related Reports

Monkeypox Virus Real-time PCR Kit Market - Global Forecast 2026-2032 - Product Image

Monkeypox Virus Real-time PCR Kit Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Monkey Pox Testing Market Report 2026 - Product Image

Monkey Pox Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
US Monkeypox Testings Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

US Monkeypox Testings Market Report: Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 83 Pages
  • United States
From
Monkeypox Virus Antigen Detection Kit Market - Global Forecast 2026-2032 - Product Image

Monkeypox Virus Antigen Detection Kit Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Monkeypox (mpox) Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Monkeypox (mpox) Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 201 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.